Telix Pharmaceuticals | TLX - Loan Capital

Stock Price
13.58
Daily Change
-0.37 -2.65%
Monthly
23.45%
Yearly
-48.91%
Q2 Forecast
12.67

Telix Pharmaceuticals reported AUD448.45M in Loan Capital for its fiscal semester ending in December of 2025.





Loan Capital Change Date
Cochlear AUD 200M 6.5M Dec/2025
CSL USD 10.42B 273M Dec/2025
Integral Diagnostics AUD 341.63M 1.98M Jun/2024
Mayne Pharma AUD 2.66M 153K Jun/2025
Medical Developments International AUD 1.5M 167K Dec/2025
Mesoblast USD 66.02M 1.72M Dec/2025
Pacific Edge NZD 551K 637K Dec/2025
Paradigm Biopharmaceuticals AUD 436.81K 336.81K Dec/2025
Polynovo AUD 15.39M 663K Dec/2025
PYC Therapeutics AUD 436.93K 188.06K Dec/2025
Ramsay Health Care AUD 11.2B 5.74B Dec/2025
ResMed USD 403.92M 4.74M Dec/2025
Sonic Healthcare AUD 4.19B 333.39M Dec/2024